Cross Country Healthcare reported record revenue of $788.7 million, a 140% increase year-over-year, and adjusted EBITDA of $97.4 million for Q1 2022. The company's performance exceeded guidance, driven by growth across all lines of business and a record number of professionals on assignment.
Achieved the highest revenue and Adjusted EBITDA in company history.
Maintained a record number of professionals on assignment.
Experienced year-over-year and sequential growth across all lines of business.
First quarter financial performance exceeded all guidance ranges.
For the second quarter of 2022, Cross Country Healthcare expects revenue between $735 million and $745 million and Adjusted EPS between $1.30 and $1.40.
Visualization of income flow from segment revenue to net income